These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37857119)

  • 1. Absent in melanoma 2 (AIM2) positive profile identifies a poor prognosis of lung adenocarcinoma patients.
    Colarusso C; Terlizzi M; Falanga A; Stathopoulos G; De Lucia L; Hansbro PM; Pinto A; Sorrentino R
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110990. PubMed ID: 37857119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIM2 upregulation promotes metastatic progression and PD-L1 expression in lung adenocarcinoma.
    Zheng JQ; Lin CH; Lee HH; Chang WM; Li LJ; Su CY; Lee KY; Chiu HW; Lin YF
    Cancer Sci; 2023 Jan; 114(1):306-320. PubMed ID: 36104978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic DNA sensor AIM2 promotes KRAS-driven lung cancer independent of inflammasomes.
    Alanazi M; Weng T; McLeod L; Gearing LJ; Smith JA; Kumar B; Saad MI; Jenkins BJ
    Cancer Sci; 2024 Jun; 115(6):1834-1850. PubMed ID: 38594840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of the AIM2 inflammasome after cigarette smoke exposure leads to an immunosuppressive lung microenvironment.
    Colarusso C; Falanga A; Di Caprio S; Terlizzi M; Pinto A; Maiolino P; Sorrentino R
    Int Immunopharmacol; 2024 Apr; 131():111832. PubMed ID: 38460301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human lung cancer-derived immunosuppressive plasmacytoid dendritic cells release IL-1α in an AIM2 inflammasome-dependent manner.
    Sorrentino R; Terlizzi M; Di Crescenzo VG; Popolo A; Pecoraro M; Perillo G; Galderisi A; Pinto A
    Am J Pathol; 2015 Nov; 185(11):3115-24. PubMed ID: 26506473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation.
    Qin Y; Pan L; Qin T; Ruan H; Zhang Y; Zhang Y; Li J; Yang J; Li W
    Front Immunol; 2022; 13():998266. PubMed ID: 36248785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma.
    Fukuda K; Okamura K; Riding RL; Fan X; Afshari K; Haddadi NS; McCauley SM; Guney MH; Luban J; Funakoshi T; Yaguchi T; Kawakami Y; Khvorova A; Fitzgerald KA; Harris JE
    J Exp Med; 2021 Sep; 218(9):. PubMed ID: 34325468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis.
    Dawson RE; Deswaerte V; West AC; Tang K; West AJ; Balic JJ; Gearing LJ; Saad MI; Yu L; Wu Y; Bhathal PS; Kumar B; Chakrabarti JT; Zavros Y; Oshima H; Klinman DM; Oshima M; Tan P; Jenkins BJ
    Gut; 2022 Aug; 71(8):1515-1531. PubMed ID: 34489308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway.
    Zhang M; Jin C; Yang Y; Wang K; Zhou Y; Zhou Y; Wang R; Li T; Hu R
    J Cell Physiol; 2019 Nov; 234(11):20161-20173. PubMed ID: 30953357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absent in melanoma 2 regulates tumor cell proliferation in glioblastoma multiforme.
    Chen PA; Shrivastava G; Balcom EF; McKenzie BA; Fernandes J; Branton WG; Wheatley BM; Petruk K; van Landeghem FKH; Power C
    J Neurooncol; 2019 Sep; 144(2):265-273. PubMed ID: 31280432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma.
    Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L
    BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-11 and AIM2 inflammasome are involved in smoking-induced COPD and lung adenocarcinoma.
    Colarusso C; Terlizzi M; Lamort AS; Cerqua I; Roviezzo F; Stathopoulos G; Pinto A; Sorrentino R
    Oncotarget; 2021 May; 12(11):1057-1071. PubMed ID: 34084280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIM2 fosters lung adenocarcinoma immune escape by modulating PD-L1 expression in tumor-associated macrophages via JAK/STAT3.
    Ye H; Yu W; Li Y; Bao X; Ni Y; Chen X; Sun Y; Chen A; Zhou W; Li J
    Hum Vaccin Immunother; 2023 Dec; 19(3):2269790. PubMed ID: 37877820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics.
    Qi M; Dai D; Liu J; Li Z; Liang P; Wang Y; Cheng L; Zhan Y; An Z; Song Y; Yang Y; Yan X; Xiao H; Shao H
    Oncogene; 2020 Mar; 39(13):2707-2723. PubMed ID: 32005973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The absent in melanoma 2 (AIM2) inflammasome in microbial infection.
    Zhu W; Zu X; Liu S; Zhang H
    Clin Chim Acta; 2019 Aug; 495():100-108. PubMed ID: 30959045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of the AIM2 molecule attenuates ischemia-reperfusion-induced spinal neuronal pyroptosis by inhibiting AIM2 inflammasome activation and subsequent release of cleaved caspase-1 and IL-1β.
    Li XQ; Yu Q; Fang B; Zhang ZL; Ma H
    Neuropharmacology; 2019 Dec; 160():107661. PubMed ID: 31181224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of AIM2 inflammasome activation alleviates GSDMD-induced pyroptosis in early brain injury after subarachnoid haemorrhage.
    Yuan B; Zhou XM; You ZQ; Xu WD; Fan JM; Chen SJ; Han YL; Wu Q; Zhang X
    Cell Death Dis; 2020 Jan; 11(1):76. PubMed ID: 32001670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DROSHA-Dependent AIM2 Inflammasome Activation Contributes to Lung Inflammation during Idiopathic Pulmonary Fibrosis.
    Cho SJ; Hong KS; Jeong JH; Lee M; Choi AMK; Stout-Delgado HW; Moon JS
    Cells; 2019 Aug; 8(8):. PubMed ID: 31434287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absent in melanoma 2 suppresses epithelial-mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells.
    Yang Y; Zhang M; Jin C; Ding Y; Yang M; Wang R; Zhou Y; Zhou Y; Li T; Wang K; Hu R
    J Cell Biochem; 2019 Oct; 120(10):17744-17756. PubMed ID: 31210372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absent in Melanoma 2 (AIM2) Regulates the Stability of Regulatory T Cells.
    Lozano-Ruiz B; Tzoumpa A; Martínez-Cardona C; Moreno D; Aransay AM; Cortazar AR; Picó J; Peiró G; Lozano J; Zapater P; Francés R; González-Navajas JM
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.